Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.
Completed · Phase 2
Conditions studied: Primary Open-Angle Glaucoma, Ocular Hypertension
In brief
To evaluate the safety and efficacy of PF-04217329.
Key facts
- Study ID
- NCT00572455
- Run by
- Pfizer
- People needed
- 318
- Starts
- 2007-12-11
- Expected to finish
- 2009-06-26
- Last updated by the study team
- 2021-04-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of primary open-angle glaucoma (including pigmentary or pseudoexfoliative) or ocular hypertension in 1 or both eyes.
- Qualifying intraocular pressure (IOP) in the same eye at the Eligibility 1 and 2 measurements.
You may not qualify if…
- Closed/barely open anterior chamber angle or a history of acute angle closure in either eye.
- Anticipate the need to initiate or modify medication (systemic or topical) that is known to affect intraocular pressure (IOP) during the study period.
Where it is running
- Sall Research Medical Center — Artesia, California, United States
- Eye Research Foundation — Newport Beach, California, United States
- North Bay Eye Associates, Inc. — Petaluma, California, United States
- Centre For Health Care — Poway, California, United States
- Atlantic Institute of Clinical Research — Daytona Beach, Florida, United States
- Florida Health Care Plans — Daytona Beach, Florida, United States
- Eye Associates of Fort Myers — Fort Myers, Florida, United States
- International Eye Associates, PA — Ormond Beach, Florida, United States
- Coastal Research Associates,LLC — Atlanta, Georgia, United States
- Omni Eye Services of Atlanta — Atlanta, Georgia, United States
- Eye Care Centers Management, Inc. — Morrow, Georgia, United States
- The Eye Group of Southern Indiana — Evansville, Indiana, United States
- Taustine Eye Center — Louisville, Kentucky, United States
- Rochester Ophthalmological Group, PC — Rochester, New York, United States
- Charlotte Eye Ear Nose and Throat Associates, PA — Charlotte, North Carolina, United States
- Cornerstone Eye Care — High Point, North Carolina, United States
- Mark J. Weiss, MD. Inc. — Tulsa, Oklahoma, United States
- Glaucoma Care Center at Century Eye Care — Bristol, Pennsylvania, United States
- Wills Eye Institute — Philadelphia, Pennsylvania, United States
- Bluestein Custom Vision — Charleston, South Carolina, United States
- Total Eye Care, PA — Memphis, Tennessee, United States
- Texan Eye Care, PA — Austin, Texas, United States
- Eye Physicians of Austin — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.